Topical Absorbable Hemostats Market Report 2026

Topical Absorbable Hemostats Market Overview

• Topical Absorbable Hemostats market size has reached to $2.17 billion in 2025 • Expected to grow to $3.03 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Increase In Surgical Procedures Fueling The Growth Of The Market Due To Rising Aging Population • Market Trend: Advances In Absorbable Hemostatic Powders Streamlining Surgical Bleeding Control • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Topical Absorbable Hemostats Market?

Topical absorbable hemostats are specialized medical solutions designed to support the body’s natural blood-clotting process during surgical or traumatic bleeding events. These agents are applied directly to bleeding sites and are uniquely formulated to be broken down and absorbed by the body over time, eliminating the need for removal. The main types of topical absorbable hemostats include gelatin-based hemostats, collagen-based hemostats, fibrin-based hemostats, cellulose-based hemostats, and others. Gelatin-based hemostats are medical products derived from purified animal gelatin, commonly sourced from pigs or cows. It uses various delivery methods, including surgical sprays, pads and gauzes, foams and films, and injectable solutions, and is applied for orthopedic surgery, cardiothoracic surgery, general surgery, neurosurgery, urology, and gynecological surgery. It is used by several end-users, including hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research institutions.

What Is The Topical Absorbable Hemostats Market Growth Forecast?

The topical absorbable hemostats market size is expected to see strong growth in the next few years. It will grow to $3.03 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to innovation in absorbable hemostatic materials, growth in minimally invasive surgeries, expansion of ambulatory surgical centers, rising geriatric population, demand for faster recovery and reduced hospital stays. Major trends in the forecast period include minimally invasive surgery adoption, surge in surgical procedures, rising focus on patient safety & reduced blood loss, growth in ambulatory surgical centers, development of biocompatible & fast-absorbing hemostats.

What Is The Driver Of The Topical Absorbable Hemostats Market?

The increasing number of surgical procedures is expected to propel the growth of the topical absorbable hemostats market going forward. Surgical procedures refer to medically performed operations involving incisions or manipulations of body tissues to diagnose, treat, or improve health conditions. The increase in surgical procedures is primarily due to the expanding aging population, as elderly individuals are more susceptible to chronic illnesses and degenerative conditions that frequently necessitate surgical treatment. Topical absorbable hemostats are advantageous during surgeries, as they rapidly manage bleeding and do not require removal, which helps shorten operation time and lowers the chance of complications. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery, a US-based professional organization, reported that aesthetic procedures reached nearly 35 million in 2023, with total surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Therefore, the increasing number of surgical procedures is driving the growth of the topical absorbable hemostats industry.

Key Players In The Global Topical Absorbable Hemostats Market

Major companies operating in the topical absorbable hemostats market are Johnson And Johnson Services Inc, Baxter International Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Gelita Medical, Advanced Medical Solutions Group Plc, 3D Matrix Ltd, Advanced Biotech Products Pvt Ltd, Curasan AG, Hemostasis LLC, Medcura Inc, Endomedix Incorporated, BioCer Entwicklungs GmbH, Starch Medical Inc, Arch Therapeutics Inc, Cura Medical BV, Z Medica LLC, Marine Polymer Technologies Inc, Ferrosan Medical Devices, Pfizer Hospital Products, Ethicon Biosurgery

Global Topical Absorbable Hemostats Market Trends and Insights

Major companies operating in the topical absorbable hemostats market are focusing on developing advanced products, such as absorbable hemostatic powder, to manage bleeding in complex or irregular wound sites. Absorbable hemostatic powders are preferred as they provide rapid bleeding control without the need for removal, reducing the risk of infection and simplifying post-surgical care. For instance, in July 2023, Baxter International, a US-based healthcare company, launched PERCLOT, an absorbable hemostatic powder. PERCLOT offers surgeons a complete range of active and passive hemostatic solutions to ensure reliable bleeding management. It's specially engineered granules pull in moisture almost instantly, transforming into an adhesive gel that physically seals the tissue surface. This gel concentrates platelets, red blood cells, and clotting factors such as thrombin and fibrinogen, accelerating the body’s own coagulation cascade. Consistent control of varied intraoperative bleeding with PERCLOT can lower transfusion requirements, curb major complications, and ultimately decrease overall treatment costs.

What Are Latest Mergers And Acquisitions In The Topical Absorbable Hemostats Market?

In May 2023, Cousin Surgery, a France-based provider of implantable medical devices, acquired PlantTec Medical for an undisclosed amount. The acquisition of PlantTec Medical will enable Cousin Surgery to expand cross-selling opportunities and strengthen its research and development capabilities. It also adds a team with specialized knowledge in surgical medical devices, enhancing the company's presence in the German market. PlantTec Medical is a Germany-based manufacturer of topical absorbable hemostats.

What Defines the Topical Absorbable Hemostats Market?

The topical absorbable hemostats market consists of sales of flowable gelatin matrix agents, bioabsorbable composite hemostatic dressings, and dual-component hemostatic kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Topical Absorbable Hemostats Market Report 2026?

The topical absorbable hemostats market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the topical absorbable hemostats industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.